Comparisons of methamphetamine psychotic and schizophrenic symptoms: A differential item functioning analysis

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 4, 2011, Pages 959-964

  Srisurapanont, Manit ^a   Arunpongpaisal, Suwanna ^b   Wada, Kiyoshi ^c   Marsden, John ^d   Ali, Robert ^e   Kongsakon, Ronnachai ^f  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c National Center of Neurology and Psychiatry   (Japan)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Differential item functioning; Methamphetamine; Psychosis; Schizophrenia; Symptom

Indexed keywords

METHAMPHETAMINE; RISPERIDONE;

ADULT; ANXIETY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DELUSION; DEPRESSION; DIFFERENTIAL ITEM FUNCTIONING; DISEASE SEVERITY; EXPLORATORY RESEARCH; FACTORIAL ANALYSIS; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANCHESTER SCALE; METHAMPHETAMINE PSYCHOSIS; NEGATIVE SYNDROME; POSITIVE SYNDROME; PSYCHOMOTOR RETARDATION; PSYCHOSIS; RATING SCALE; SCHIZOPHRENIA; SPEECH DISORDER; STATISTICAL ANALYSIS;

ADULT; AFFECT; AMPHETAMINE-RELATED DISORDERS; ANXIETY; CENTRAL NERVOUS SYSTEM STIMULANTS; DATA INTERPRETATION, STATISTICAL; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; METHAMPHETAMINE; MOTIVATION; OUTPATIENTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOSES, SUBSTANCE-INDUCED; SCHIZOPHRENIC PSYCHOLOGY; SPEECH;

EID: 79956040605     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.01.014     Document Type: Article

References (27)

1. Ali R., Baigent M., Marsden J., Montiero M., Srisurapanont M., Sunga A., et al. WHO Multi-Site Project on Methamphetamine-induced Psychosis: A descriptive report of findings from participating countries 2006, Drug & Alcohol Services South Australia, Adelaide (South Australia).
2. Ali R., Marsden J., Srisurapanont M., Sunga A., Baigent M., Monteiro M. Methamphetamine psychosis in Australia, Philippines, and Thailand: Recommendations for acute care and clinical inpatient management. Addict Disord Their Treat 2010, 9:143-149.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, 4-TR ed. Washington (DC).
4. Andreasen N.C. The scale for the assessment of negative symptoms (SANS) 1983, University of Iowa, Iowa City.
5. Andreasen N.C. The scale for the assessment of positive symptoms (SAPS) 1984, University of Iowa, Iowa City.
6. Andreasen N.C., Carpenter J.W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005, 162:441-449.
7. Arunpongpaisal S., Srisurapanont M., Kongsakon R., Kitiwattanagul K., Samanwongthai U. Risperidone long-acting injection (RLAI): the 12-week efficacy and tolerability in Thai patients with chronic schizophrenia. J Med Assoc Thai 2010, 93:343-350.
8. Bell D.S. Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry 1965, 111:701-707.
9. Griffith J.D., Cavanaugh J., Held J., Oates J. Dextroamphetamine: evaluation of psychomimetic properties in man. Arch Gen Psychiatry 1972, 26:97-100.
10. Harvey C., Curson D., Pantelis C., Taylor J., Barnes T. Four behavioural syndromes of schizophrenia. Br J Psychiatry 1996, 168:562-570.
11. Hermens D.F., Lubman D.I., Ward P.B., Naismith S.L., Hickie I.B. Amphetamine psychosis: a model for studying the onset and course of psychosis. MJA 2009, 190:S22-S25.
12. Jackson H.J., Burgess P.M., Minas I.H., Joshua S.D. Psychometric properties of the Manchester scale. Acta Psychiatr Scand 1990, 81:108-113.
13. Johnstone E.C., Crow T.J., Frith C.D., Carney M.W., Price J.S. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet 1978, 1(8069):848-851.
14. Krawiecka M., Goldberg D., Vaughan M. A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr Scand 1977, 55:299-308.
15. Lai J.S., Teresi J., Gershon R. Procedures for the analysis of differential item functioning (DIF) for small sample size. Eval Health Prof 2005, 28:283-294.
16. Ramsay J.O. Kernel smoothing approaches to non parametric item curve estimation. Psychometrika 1991, 56:611-630.
17. Ramsay J.O. TesGraf: A program for the graphical analysis of multiple choice test and questionnaire data 2001, McGill University, Montreal, Canada.
18. Robinson T., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986, 396:157-198.
19. Santor D.A., Ramsay J.O., Suroff D.C. Nonparametric item analyses of the Beck Depression Inventory: evaluating gender item bias and response option weights. Psychol Assess 1994, 6:255-270.
20. Scott N.W., Fayers P.M., Aaronson N.K., Bottomley A., de Graeff A., Groenvold M., et al. A simulation study provided sample size guidance for differential item functioning (DIF) studies using short scales. J Clin Epidemiol 2009, 62:288-295.
21. Sheehan D., Lecrubier Y., Sheehan K., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59:22-33.
22. Srisurapanont M., Ali R., Marsden J., Sunga A., Wada K., Montiero M. Psychotic symptoms in methamphetamine psychotic in-patients. Int J Neuropsychopharmacol 2003, 6:347-352.
23. Teresi J.A., Fleishman J.A. Differential item functioing and health assessment. Qual Life Res 2007, 16:33-42.
24. Tomiyama G. Chronic schizophrenia-like states in methamphetamine psychosis. Jpn J Psychiatry Neurol 1990, 44:531-539.
25. Weinstock L.M., Strong D., Uebelacker L.A., Miller I.W. DSM-IV depressive symptom expression among individuals with a history of hypomania: a comparison to those with or without a history of mania. J Psychiatr Res 2010, 44:979-985.
26. Yui K., Ikemoto S., Ishiguro T., Goto K. Studies of amphetamine or methamphetamine psychosis in Japan. Ann NY Acad Sci 2000, 914:1-12.
27. Zorick T.S., Rad D., Rim C., Tsuang J. An overview of methamphetamine-induced psychotic syndromes. Addict Disord Their Treat 2008, 7:143-156.